Search Results - "Vives, Àngels"

Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial by Mendoza, Manel, Bonacina, Erika, Garcia-Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez-Quesada, Eva, Ricart, Marta, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Ferrer-Costa, Roser, Martin, Lourdes, Rodríguez-Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal-Sagnier, Laia, Teixidor, Mireia, Orizales-Lago, Carmen, Pérez-Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna

“…Aspirin reduces the incidence of preterm preeclampsia by 62% in pregnant individuals at high risk of preeclampsia. However, aspirin might be associated with an…”
Get full text

Placental growth factor at 24–28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial by Ricart, Marta, Bonacina, Erika, Garcia‐Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez‐Quesada, Eva, Maroto, Anna, Mingo, Laura, Pintado, Elena, Ferrer‐Costa, Roser, Martín, Lourdes, Rodriguez‐Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Pratcorona, Laia, Teixidor, Mireia, Orizales‐Lago, Carmen, Ocaña, Vanesa, Barco, Esther, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…Introduction This study aims to evaluate the safety of discontinuing aspirin treatment at 24–28 weeks in women at high risk after first‐trimester combined…”
Get full text

Mid‐trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre‐eclampsia: Post‐hoc analysis of StopPRE trial by Bonacina, Erika, Garcia‐Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez‐Quesada, Eva, Ricart, Marta, Maroto, Anna, Mingo, Laura, Pintado, Elena, Castillo‐Ribelles, Laura, Martín, Lourdes, Rodriguez‐Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal‐Sagnier, Laia, Teixidor, Mireia, Orizales‐Lago, Carmen, Pérez‐Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…Objective To assess whether aspirin treatment can be discontinued in pregnancies with normal uterine artery pulsatility index (≤90th percentile) at 24–28…”
Get full text

Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor by Garcia‐Manau, Pablo, Bonacina, Erika, Serrano, Berta, Caamiña, Sara, Ricart, Marta, Lopez‐Quesada, Eva, Vives, Àngels, Lopez, Monica, Pintado, Elena, Maroto, Anna, Catalan, Sara, Dalmau, Marta, Del Barco, Ester, Hernandez, Alina, Miserachs, Marta, San Jose, Marta, Armengol‐Alsina, Mireia, Carreras, Elena, Mendoza, Manel

“…Introduction Pre‐eclampsia affects 2%–8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First‐trimester…”
Get full text

Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study) by Cobo, Teresa, Aldecoa, Victoria, Bartha, Jose Luis, Bugatto, Fernando, Paz Carrillo-Badillo, María, Comas, Carmina, Diago-Almeda, Vicente, Ferrero, Silvia, Goya, Maria, Herraiz, Ignacio, Martí-Malgosa, Laia, Olivella, Anna, Paulés, Cristina, Vives, Àngels, Figueras, Francesc, Palacio, Montse, Gratacós, Eduard, Boada, David, Meler, Eva, Peguero, Anna, Ruiz-Martínez, Sara, Galindo, Alberto, Vilalain González, Cecilia, Forcén, Laura, Brañas, Patricia M, Garcia, Itziar, Vargas, Mirea, Martínez-Varea, Alicia, PratCorona, Laia, Cuerva, Marcos, Illescas, Tamara, López-Guerrero, Miguel Angel, Facio, MºCarmen, Garrido, Carmen, Medina, Carmen

“…IntroductionThe majority of women admitted with threatened preterm labour (PTL) do not delivery prematurely. While those with microbial invasion of the…”
Get full text

Development of quality of care indicators from systematic reviews: the case of hospital delivery by Bonfill, Xavier, Roqué, Marta, Aller, Marta Beatriz, Osorio, Dimelza, Foradada, Carles, Vives, Angels, Rigau, David

“…The objective of this research is to generate quality of care indicators from systematic reviews to assess the appropriateness of obstetric care in hospitals…”
Get full text

Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study by Palacio, Montse, MD, PhD, Bonet-Carne, Elisenda, MSc, PhD, Cobo, Teresa, MD, PhD, Perez-Moreno, Alvaro, MSc, Sabrià, Joan, MD, PhD, Richter, Jute, MD, PhD, Kacerovsky, Marian, MD, PhD, Jacobsson, Bo, MD, PhD, García-Posada, Raúl A., MD, Bugatto, Fernando, MD, PhD, Santisteve, Ramon, MD, Vives, Àngels, MD, Parra-Cordero, Mauro, MD, PhD, Hernandez-Andrade, Edgar, MD, PhD, Bartha, José Luis, MD, PhD, Carretero-Lucena, Pilar, MD, Tan, Kai Lit, MRCOG, Cruz-Martínez, Rogelio, MD, PhD, Burke, Minke, MD, Vavilala, Suseela, MD, Iruretagoyena, Igor, MD, Delgado, Juan Luis, MD, PhD, Schenone, Mauro, MD, Vilanova, Josep, MD, PhD, Botet, Francesc, MD, PhD, Yeo, George S.H., FRCOG, Hyett, Jon, MD, PhD, Deprest, Jan, MD, PhD, Romero, Roberto, MD, DMedSci, Gratacos, Eduard, MD, PhD

“…Background Prediction of neonatal respiratory morbidity may be useful to plan delivery in complicated pregnancies. The limited predictive performance of the…”
Get full text

Placental growth factor at 24–28weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial by Ricart, Marta, Bonacina, Erika, Pablo Garcia‐Manau, López, Monica, Caamiña, Sara, Vives, Àngels, Eva Lopez‐Quesada, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Roser Ferrer‐Costa, Martín, Lourdes, Alicia Rodriguez‐Zurita, Garcia, Esperanza, Mar Pallarols, Pratcorona, Laia, Teixidor, Mireia, Carmen Orizales‐Lago, Ocaña, Vanesa, Esther del Barco, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…IntroductionThis study aims to evaluate the safety of discontinuing aspirin treatment at 24–28 weeks in women at high risk after first‐trimester combined…”
Get full text

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial by Mendoza, Manel, Bonacina, Erika, Garcia-Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez-Quesada, Eva, Ricart, Marta, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Ferrer-Costa, Roser, Martin, Lourdes, Rodríguez-Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal-Sagnier, Laia, Teixidor, Mireia, Orizales-Lago, Carmen, Pérez-Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna

“…Preeclampsia affects up to 4% of pregnancies and is marked by the development of hypertension and proteinuria after 20 weeks of gestation. Complications…”
Get full text

310: Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study by Palacio, Montse, Bonet-carne, Elisenda, Cobo, Teresa, Perez-moreno, Alvaro, Sabrià, Joan, Richter, Jute, Kacerovsky, Marian, Jacobsson, Bo, García-posada, Raúl A, Bugatto, Fernando, Santisteve, Ramon, Vives, Àngels, Parra-cordero, Mauro, Hernandez-andrade, Edgar, Bartha, José Luis, Carretero-lucena, Pilar, Lit, Kai, Cruz, Rogelio, Burke, Minke, Vavilala, Suseela, Iruretagoyena, Igor, Delgado, Juan Luis, Schenone, Mauro, Vilanova, Josep

Get full text

Maternal History and Uterine Artery Doppler in the Assessment of Risk for Development of Early- and Late-Onset Preeclampsia and Intrauterine Growth Restriction by Llurba, Elisa, Carreras, Elena, Gratacós, Eduard, Juan, Miquel, Astor, Judith, Vives, Angels, Hermosilla, Eduard, Calero, Ines, Millán, Pilar, García-Valdecasas, Bárbara, Cabero, Lluís

“…Objective. To examine the value of one-step uterine artery Doppler at 20 weeks of gestation in the prediction pre-eclampsia (PE) and/or intrauterine growth…”
Get full text

Implementation of routine first‐trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness study by Mendoza, Manel, Bonacina, Erika, Serrano, Berta, Ricart, Marta, Martin, Lourdes, Lopez‐Quesada, Eva, Vives, Angels, Maroto, Anna, Garcia‐Manau, Pablo, De Antonio, Clementina, Tusquets, Cristina, Moreano, Gabriela, Armengol‐Alsina, Mireia, Carreras, Elena

“…Objective To evaluate the clinical effectiveness of the routine first‐trimester screening for preeclampsia (PE) after being implemented in six Catalan…”
Get full text

La relevancia de los Servicios de Emergencias en la donación: el ejemplo de España by Jiménez Fàbrega, Xavier, Carmona Jiménez, Francesc, Mora Vives, Angels, Solà Muñoz, Silvia

Get full text

Shared risk factors for COVID‐19 and preeclampsia in the first trimester: An observational study by Serrano, Berta, Mendoza, Manel, Garcia‐Aguilar, Paula, Bonacina, Erika, Garcia‐Ruiz, Itziar, Garcia‐Manau, Pablo, Gil, Judit, Armengol‐Alsina, Mireia, Fernandez‐Hidalgo, Nuria, Sulleiro, Elena, Lopez‐Martinez, Rosa Maria, Ricart, Marta, Martin, Lourdes, Lopez‐Quesada, Eva, Vives, Angels, Maroto, Anna, Maiz, Nerea, Suy, Anna, Carreras, Elena

“…Introduction The association between preeclampsia and coronavirus disease 2019 (COVID‐19) is under study. Previous publications have hypothesized the existence…”
Get full text

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial by Garcia-Manau, Pablo, Mendoza, Manel, Bonacina, Erika, Martin-Alonso, Raquel, Martin, Lourdes, Palacios, Ana, Sanchez, Maria Luisa, Lesmes, Cristina, Hurtado, Ivan, Perez, Esther, Tubau, Albert, Ibañez, Patricia, Alcoz, Marina, Valiño, Nuria, Moreno, Elena, Borrero, Carlota, Garcia, Esperanza, Lopez-Quesada, Eva, Diaz, Sonia, Broullon, Jose Roman, Teixidor, Mireia, Chulilla, Carolina, Gil, Maria M, Lopez, Monica, Candela-Hidalgo, Amparo, Salinas-Amoros, Andrea, Moreno, Anna, Morra, Francesca, Vaquerizo, Oscar, Soriano, Beatriz, Fabre, Marta, Gomez-Valencia, Elena, Cuiña, Ana, Alayon, Nicolas, Sainz, Jose Antonio, Vives, Angels, Esteve, Esther, Ocaña, Vanesa, López, Miguel Ángel, Maroto, Anna, Carreras, Elena

“…Background: Fetal smallness affects 10% of pregnancies. Small fetuses are at a higher risk of adverse outcomes. Their management using estimated fetal weight…”
Get full text

Children capability to perform CPR, is useful to teach them so young? by Jimenez-Fabrega, Xavier, Carmona-Jimenez, Francesc, Escalada-Roig, Xavier, Mora-Vives, Angels, Rubio-Moron, Marisa, Trayner-Guixens, Marta, Puig-Mari, Anna, Palma-Padro, Pilar

Get full text

The relevance of Emergency services in donation: the example of Spain by Jiménez Fàbrega, Xavier, Carmona Jiménez, Francesc, Mora Vives, Angels, Solà Muñoz, Silvia

Get full text

Actuación integral en el paciente con síndrome coronario agudo con elevación del segmento ST: 10 años de Código Infarto en Cataluña by Jiménez Fàbrega, Xavier, Solà Muñoz, Silvia, Carmona Jiménez, Francesc J., Mora Vives, Angels, Gómez Pardell, Victoria, Gibert Preixens, Jordi

Get full text

Impacto del cambio de fármaco utilizado en la inducción del parto: misoprostol vaginal vs. dinoprostona by Molinero Sampedrano, Istria, Romero Ramírez, Marino, García Cancela, Esperanza, Jovell Fernández, Esther, Vives Argilagós, Àngels

“…Resumen Objetivo Comparar la eficacia, seguridad y el coste de 2 pautas para la maduración cervical en la inducción del parto: misoprostol vaginal vs…”
Get full text

Type-1 and Type-2 Cytokines in Human Decidual Tissue and Trophoblasts from Normal and Abnormal Pregnancies Detected by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) by Vives, Angels, Balasch, Juan, Yagüe, Jordi, Quintó, Llorenç, Ordi, Jaume, Vanrell, Juan A.

“…Vives A, Balasch J, Yagüe J, Quintó L, Ordi J, Vanrell JA. Type‐1 and type‐2 cytokines in human decidual tissue and trophoblasts from normal and abnormal…”
Get full text